🇺🇸 FDA
Patent

US 12066246

Target residual moisture content for lyophilized drug product

granted A61KA61K9/19

Quick answer

US patent 12066246 (Target residual moisture content for lyophilized drug product) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K9/19